A collaboration between the Serum Institute of India (SII), the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance, will see an extra 100 million doses of a future vaccine delivered to low- and middle-income countries in 2021, Gavi said in a statement Tuesday.
Gavi is an organization focused on vaccinating children in low-income countries.
The deal means the world’s poorest countries have secured 200 million doses, Gavi said.
Seth Berkley, the company’s CEO, said the collaboration would help “ensure no country is left behind when it comes to access to a Covid-19 vaccine.”
No country, rich or poor, should be left at the back of the queue when it comes to Covid-19 vaccines; this collaboration brings us another step closer to achieving this goal,” Berkley said.
The collaboration will provide upfront capital to SII, the world’s largest vaccine manufacturer by volume, to help it increase manufacturing capacity so that, once a vaccine, or vaccines are available, doses can be distributed at scale.
The vaccines will have a ceiling price of $3 per dose for 92 of the world’s low income countries.
Seventy-five countries have formally committed to providing funding to meet part of the cost for procuring the vaccine for poorer nations.